Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Sarcoma 2Other solid neoplasm 2Genitourinary 2CNS 2Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Rectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Islet Cell 2Carcinoma, Hepatocellular 2Vipoma 1Uveal Melanoma 1Stomach Neoplasms 1Somatostatinoma 1Pheochromocytoma 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Insulinoma 1Glucagonoma 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Medullary 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Adenoma, Islet Cell 1Adenocarcinoma Of Esophagus 1

Interventions

Radiosurgery 2Everolimus 2sargramostim 1pasireotide 1fostamatinib 1aldesleukin 1Tamoxifen 1Sirtuins 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Microscopy, Electron 1Melphalan 1Immunotherapy 1Drug Therapy 1Doxorubicin 1Cisplatin 1CYT-6091 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Melphalan × Endocrine × Clear all
NCT00019786 2012-03-23

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
67 enrolled
EndocrineGastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Liver Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Islet Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡